Friday, December 4, 2015

new treatment possibilities for vision loss

The article that I stumbled on this week covers stem cells. Researchers at John Hopkins have developed a method to transform human stem cells into retinal ganglion cells. The researchers define that retinal ganglion cells are types of nerve cells that are located within the retina that transmit visual signals from the eye to the brain. They also state that if someone were to lose the cells, they would suffer a complete or partial loss of vision. The death of the cells could arise from conditions such as glaucoma and multiple sclerosis. The way that the researchers were able to transform the stem cells is by using the tool CRISPR-Cas9. The researchers inserted the fluorescent protein gene into the stem cells' DNA. This fluorescent protein would be fluoresced only if a gene named BRN3B (POU4F2) was expressed. According to the researchers “BRN3B is expressed by mature retinal ganglion cells, so once a cell differentiated into a retinal ganglion cell, it would appear red under a microscope”. This is because the fluorescent protein would fluoresce red. The researchers then sorted the cells via a technique called fluorescence-activated cell sorting. They were then able to study the transformed stem cells to the point where they discovered that they showed similar biological and physical properties seen in retinal ganglion cells that are produced naturally. This research is important because it could lead to other treatment options for patients with glaucoma and MS.

here is the link to the article:
http://www.news-medical.net/news/20151201/Johns-Hopkins-researchers-develop-method-to-turn-stem-cells-into-retinal-ganglion-cells.aspx